Skip to main content

Table 2 Univariate Analysis of Clinical Outcome As A Function of MIBC By Quartile

From: The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer

Quartile N FFBF FFM CSS OS
5 yr 8 yr 5 yr 8 yr 5 yr 8 yr 5 yr 8 yr
<10% 144 91% 91% 97% 95% 100% 96% 91% 72%
   (88–94) (88–94) (95–99) (92–98)   (93–99) (88–94) (55–79)
<30% 134 93% 79% 97% 93% 100% 100% 96% 92%
   (90–96) (72–86) (95–99) (88–98)    (94–98) (89–95)
<70% 147 82% 70% 95% 83% 99% 99% 95% 82%
   (88–86) (63–77) (93–97) (77–89) (98–100) (98–100) (93–97) (77–87)
70 +% 164 74% 51% 91% 82% 94% 94% 87% 77%
   (71–78) (43–59) (88–94) (77–87) (92–96) (92–96) (84–90) (72–82)
p-value Overall <0.0001 0.0047 0.0071 0.061
p-value Quartiles 1-3 0.009 0.12 0.29 0.30
  1. Rates at five and eight years along with the standard error of the mean.